1.11 USD
↘ 0.11 (8.68%)LIVE (AS OF 02:40 PM EDT)
ALX Oncology Holdings Inc. Common Stock
ALXONASDAQ • USD
Market: OPEN
ALX Oncology Holdings Inc. Common Stock (ALXO) trades at $1.11 per share. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation metrics suggest ALXO is trading at a discount to its peers, earning an "Attractively Valued" rating.
Technical & fundamental data as of Oct 5, 2026.
Open?$1.19
High?$1.24
Low?$1.11
Prev. Close?$1.21
Volume?534.4K
Avg. Volume?1.1M
VWAP?$1.15
Rel. Volume?0.49x
Bid / Ask
Bid?$1.10 × 900
Ask?$1.11 × 1.1K
Spread?$0.01
Midpoint?$1.11
Valuation & Ratios
Market Cap?167.3M
Shares Out?138.3M
Float?102.3M
Float %?76.0%
P/E Ratio?N/A
P/B Ratio?1.23
EPS?-$0.58
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. It is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.
Employees
48
Market Cap
167.3M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2020-07-17
Address
323 ALLERTON AVENUE
SOUTH SAN FRANCISCO, CA 94080
Phone: 650-466-7125
SOUTH SAN FRANCISCO, CA 94080
Phone: 650-466-7125
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?65
Short Sent.?68
Piotroski F-Score?0/9Weak
Altman Z-Score?-3.26Distress
Confidence?48%Low
Short InterestHigh
Short % of Float?6.13%Elevated
Short Interest?6.3M
Days to Cover?7.8
Free Float102.3M
Avg Daily Volume805.4K
Settlement Date2026-09-15
Financial Health
Current Ratio?9.71Strong
Quick Ratio?9.71Strong
Cash Ratio?1.54Strong
Debt/Equity?0.07Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?1.23CHEAP▾
Peers100
S&P93
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-1.9CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-59.4%WEAK▾
S&P3
ROA?-50.3%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-70950000
Enterprise Value?$154.3M
Fundamentals ratios updated end of day